CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
…
continue reading
CureTalks features leading medical experts in conversation with a panel of patients/advocates about latest research and treatments under development.
…
continue reading
The Multiple Myeloma Research Foundation provides educational programs to help people with myeloma, family members, caregivers, and healthcare professionals learn more about the disease and today's most promising treatment options, including clinical trials, from leading multiple myeloma doctors and researchers.
…
continue reading
HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.
…
continue reading
She’s a fashion designer from Brooklyn. He's a nonprofit director from the mountains of North Carolina.They both have cancer and they want to share how to make your lives better.
…
continue reading
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
…
continue reading
Sit back and listen to Ulf-Henrik Mellqvist talking about the significant developments in the field of multiple myeloma treatment. What do the new possibilities mean for patients and doctors? And why should young doctors looking to specialize go into hematology?
…
continue reading
Targeted Oncology brings you Targeted Talks, a monthly podcast featuring discussions with academic and community oncologists surrounding advancements in cancer research and best practices for patient management.
…
continue reading
Yo, not to get all heavy on you, but this Podcast was born out of my personal experience as a Black man with cancer. I’ve learned a lot... sooo peep this. Black Americans carry a disproportionate cancer burden, including the highest mortality rates from most cancers, and slowest time to diagnosis of any other race. Not only are Black Americans 41% more likely to die from cancer, but they also top the charts in heart disease, diabetes, and obesity too. So, what’s shaking and taking our lives ...
…
continue reading
Welcome to the Clinical Care Solutions Oncology podcast channel. Our podcast shows give you quick access to important content when you need it - at home, at your desk, or on the go.
…
continue reading
Peer-Spectives is a podcast series that is moderated by Robert Figlin, MD, and features various oncology thought-leaders covering the latest clinical developments in a wide range of tumor types.
…
continue reading
The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.
…
continue reading
The New FDA Approvals podcast is a weekly podcast that aims to help clinicians, medical writers, and pharmaceutical industry executives stay up to date on the latest FDA approvals. Join Dr. Emma Hitt Nichols each Monday morning for an update on the previous week’s FDA activities.
…
continue reading
On this podcast, you'll find interviews with high-performing successful individuals in Life Sciences. On a weekly basis, we cover their proven methods, principles, strategies, and mindsets to implement new technologies that scale to meet the needs of people in our world.
…
continue reading
The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.
…
continue reading
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
…
continue reading
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us ...
…
continue reading
This is a podcast on latest advances in the understanding and management of blood cancers. Here, we will bring a wide range of experts within hematologic malignancies to discuss various topics in depth. Host: Raj Chakraborty, MD from Columbia University, New York, Ashwin Kishtagari, MD, from Vanderbilt University, Nashville, and Edward Cliff, MD, from Harvard University, Boston Tweet your suggestions and feedback to @rajshekharucms @AshKishtagari @Eddie_Cliff @BloodCancerTalk
…
continue reading
Welcome to the mibo show, where we focus on mind and body wellness… let’s talk about it!!! Each episode our guests will talk about their mental and/or physical health journey or that of their family. We will also have subject matter experts talk health facts and stats, best practices for wellness, and provide strategies to encourage us all how to live a healthy lifestyle where we prioritize our mind and body wellness on a regular basis!
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
…
continue reading
Patient Empowerment Network (PEN) is a 501(c)(3) non-profit organization. PEN’s mission is to fortify cancer patients and care partners with the knowledge and tools to boost their confidence, put them in control of their healthcare journey, and assist them in receiving the best, most personalized care available to ensure they have the best possible outcome.Our programs enhance patient health literacy to enable shared decision-making and provide informational and educational resources to empo ...
…
continue reading
Listen to podcasts with key opinion leaders in multiple therapy areas, discussing hot topics including topic overviews, expert opinions and conference overviews. Brought to you by the Adis Journals Group, part of Springer Nature. The primary audience for these podcasts are healthcare professionals, and are published and citable through the journals.
…
continue reading
Lan-Lan Smith, Editor-in-Chief, and Emma Cookson, Senior Editor at The Lancet Haematology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from racial and ethnic disparities in leukaemia survival outcomes to resuscitation with blood products compared with saline, the link between mental health and lymphoma to haemol ...
…
continue reading
1
Cancer Healing Journeys by ZenOnco.io & Love Heals Cancer
Kishan Shah, Vasundhara Raghavan, Nadia Raju, Prabhat Kumar Verma, Imran Shaikh, Vijay Sharnangat, Premitha R, Shreshtha Mittal, Divya Sharma, Bhumi Ben, Divya Par, Farida Rizwan, Asmita Bhattacharya, Sidharth Ghosh
"In life, winning and losing will both happen. What is never acceptable is quitting." When you feel that you are alone in this journey, you really are not alone. There are countless warriors who have gone through a similar journey like what you are going through today; they have felt the immense pain that you are experiencing; but in the end, they have healed themselves from cancer. Some talk about their own journey as you are listening to this, while some have defeated pain forever, but in ...
…
continue reading
Hear stories of hope and inspiration for a cancer-free future from the annual WEEI/NESN Jimmy Fund Radio-Telethon presented by Arbella Insurance.
…
continue reading
HemeTalks: Conversations in Hematology Education is the latest podcast channel by the American Society of Hematology (ASH)! Explore educational content crafted by subject-matter experts from the ASH tailored to fulfill your professional education requirements. Whether you are a clinician or researcher, HemeTalks provides innovative education designed for every career stage and subspecialty.
…
continue reading
The Cancer Revolution podcast series looks to explore all areas of integrative, traditional and alternative means of beating cancer and creating sustained good health, for the young folks and old. Our topics will include areas such as immune system, metabolic theory, epigenetic, microbial connections, diet, mitigating side effects of cancer treatments, detoxification methods, anticancer nutrition, the latest news and stories in institutional cancer research
…
continue reading
Hey everyone! Do you think we can grow a brain outside our body? Welcome to the podcast where we take stem cells very "seriously". We invite everyone who is interested in the topic of stem cells to follow along. We highlight all of the incredible discoveries of stem cells from their origins to their therapeutic applications in modern medicine.Our podcast is friendly, informative, and intrigues curious minds to further our understanding of the complexities of stem cells.
…
continue reading
Bringing you untold stories behind luminaries and legends of the New York City’s running culture. A new show from the CITIUS MAG Podcast Network. Hosted by Leigh Anne Sharek and Chris Chavez. Support us on Patreon: https://patreon.com/runnersofnyc Be sure to check out CITIUSMAG.com for all your latest running commentary. Support the show and rep Runners of NYC: https://www.bonfire.com/runners-of-nyc-podcast/ ▶ Follow us: twitter.com/RunnersOfNYC | Instagram.com/RunnersOfNYC | Facebook.com/Ci ...
…
continue reading
Audio-reports and interviews done in collaboration with Audio Medica and its founding Editor Peter Goodwin. Audio Medica's Audio Journal of Oncology has been bringing lively listen-in shows to members of the cancer care team in various audio formats since 1992. Scientific Editors are George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVie, MD, of the European Institute of Oncology and Chair of the Editorial Board of OT's UK Edition; Pat Price, MD, of Christie Hospital, also on ...
…
continue reading
The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland and covers a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The Onco'Zine Brief is a sponsor-supported, program for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends. If you like to join us as a sponsor or advertisers, download our med ...
…
continue reading
As the leading authoritative, peer-reviewed audio source of oncology clinical news for clinicians and healthcare professionals, the AJO Podcast regularly brings you exclusive interviews with the world's leading researchers and clinicians responsible for pushing out the boundaries of science and practice. Medicine, screening, radiotherapy, surgery, clinical trials, cancer care, epidemiology and prevention are covered impartially to give busy cancer professionals access to conversational spoke ...
…
continue reading
1
Enhancing Treatment Efficacy in Multiple Myeloma at ASCO24
22:10
22:10
Play later
Play later
Lists
Like
Liked
22:10
Drs. John Sweetenham and Marc Braunstein discuss practice-changing studies in hematologic malignancies that were featured at the 2024 ASCO Annual Meeting, including the ASC4FIRST trial in chronic myeloid leukemia and IMROZ and CARTITUDE-4 in multiple myeloma. TRANSCRIPT Dr. John Sweetenham: Hello, I'm Dr. John Sweetenham from UT Southwestern’s Haro…
…
continue reading
1
Stephanie Oestreich: Advancing Myeloma Research & Investment
28:49
28:49
Play later
Play later
Lists
Like
Liked
28:49
In this episode of the Life Science Success Podcast we are joined by Stephanie Oestreich, Managing Director of the Myeloma Investment Fund, who has an extensive background in life sciences, leadership, and a unique perspective as a semi-professional violinist. Stephanie shares her extensive background in life sciences and leadership, and discusses …
…
continue reading
1
"Very Important" Myeloma Data: ASCO Highlights, Smoldering Challenges, and More
12:32
12:32
Play later
Play later
Lists
Like
Liked
12:32
From ASCO 2024, Dr. Robert Figlin speaks with Dr. Samer Al Hadadi from University of Arkansas. "Very Important" Myeloma Data: ASCO Highlights, Smoldering Challenges, and More.
…
continue reading
1
Erica Campbell - Multiple Myeloma: Know The Risks
45:51
45:51
Play later
Play later
Lists
Like
Liked
45:51
In this episode of the mibo show, Shanti Das talks with Grammy Award-winning Gospel artist and radio show host Erica Campbell. We discuss raising awareness about multiple myeloma, and Campbell shares her father's journey with the rare blood cancer. We also speak with Dr. Monique Hartley-Brown, a hematologist oncologist and emerging leader in the fi…
…
continue reading
- Understanding Precision Medicine: Overview & Value of Precision Medicine- How Precision Medicine is Different from Targeted Treatments?- Precision Medicine Role’s in Informing Treatment Decisions: Predicting Response to Treatment- The Role of Precision Medicine in Deciding the Treatment for Lung Cancer, Leukemia & Colon Cancer- Talking with Your …
…
continue reading
1
Episode 46. Updates in Myeloma MRD with Dr. Ben Derman and Dr. Manni Mohyuddin
57:48
57:48
Play later
Play later
Lists
Like
Liked
57:48
In this episode, we dive into updates in Minimal Residual Disease (MRD) in multiple myeloma, along with the FDA ODAC meeting in April 2024 to decide on MRD as a surrogate endpoint for accelerated approval. Our guests are Dr. Benjamin Derman and Dr. Manni Mohyuddin. Here are the key papers we discussed: 1. Recording of FDA ODAC meeting: https://www.…
…
continue reading
1
Nilotinib with or without cytarabine for Philadelphia-positive AML; thrombosis risk in Factor V Leiden and Prothrombin G20210A; ctDNA improves prognostic prediction in relapsed/refractory multiple myeloma ...
23:05
23:05
Play later
Play later
Lists
Like
Liked
23:05
In this week's episode we’ll discuss the safety and efficacy of nilotinib with or without cytarabine in Philadelphia-positive acute lymphoblastic leukemia; learn more about thrombosis risk in double heterozygous carriers of Factor V Leiden and prothrombin G20210A and discuss the utility of circulating cell-free tumor DNA in prognostic prediction in…
…
continue reading
1
Highlights from ISA 2024: the importance of early diagnosis in AL amyloidosis, trials in progress & patient selection for SCT
8:43
8:43
Play later
Play later
Lists
Like
Liked
8:43
Welcome to today's VJHemOnc podcast episode, where we will be sharing key highlights from the 2024 International Symposium on Amyloidosis (ISA), which was held in Rochester, MN. This podcast covers a variety of unmet needs in light chain (AL) amyloidosis, as well as emerging trials in the field. Join leading experts Mario Nuvolone, MD, PhD, Univers…
…
continue reading
1
Capvaxive Pneumococcal Conjugate Vaccine, Elevidys for DMD, Krazati for CRC, Keytruda for Endometrial Cancer, Skyrizi for UC, Tremfya for Crohn’s Disease
10:08
10:08
Play later
Play later
Lists
Like
Liked
10:08
Visit nascentmc.com for the full writup of this episode and medical writing assistance. Visit learnamastyle.com for free downloads directed towards medical writing and editing. • The FDA has approved the 21-valent pneumococcal conjugate vaccine, CAPVAXIVE™ (Merck), for the prevention of invasive disease and pneumonia in adults aged 18 years and old…
…
continue reading
1
ASCO24: Transforming the Lung Cancer Treatment Landscape
33:17
33:17
Play later
Play later
Lists
Like
Liked
33:17
Drs. Vamsi Velcheti and Nathan Pennell discuss novel approaches and key studies in lung cancer that were showcased at the 2024 ASCO Annual Meeting, including the Plenary abstracts LAURA and ADRIATIC. TRANSCRIPT Dr. Vamsi Velcheti: Hello, I am Dr. Vamsi Velcheti, your guest host for the ASCO Daily News Podcast today. I'm a professor of medicine and …
…
continue reading
1
Reassessing the CLL prognostic index; ADAMTS13 conformation and risk of relapse in immune-mediated TTP; haploidentical bone marrow transplant in sickle cell disease
23:39
23:39
Play later
Play later
Lists
Like
Liked
23:39
In this week's episode we’ll discuss the prognostic value of the Chronic Lymphocytic Leukemia International Prognostic Index in the era of targeted therapies, learn how peak ADAMTS13 activity can be used to assess ADAMTS13 conformation and risk of relapse in immune-mediated thrombotic thrombocytopenic purpura, and discuss the findings from a phase …
…
continue reading
1
ESOPEC and Other Key GI Studies at ASCO24
17:39
17:39
Play later
Play later
Lists
Like
Liked
17:39
Dr. Shaalan Beg highlights practice-changing studies in GI cancers featured at the 2024 ASCO Annual Meeting, including the ESOPEC trial in esophageal adenocarcinoma and durable responses to PD-1 blockade alone in mismatch repair-deficient locally advanced rectal cancer. TRANSCRIPT Geraldine Carroll: Welcome to the ASCO Daily News Podcast. I'm Geral…
…
continue reading
1
Immunotherapy at ASCO24: NADINA and Other Key Studies
34:51
34:51
Play later
Play later
Lists
Like
Liked
34:51
Dr. Diwakar Davar and Dr. Jason Luke discuss advances in the neoadjuvant immunotherapy space that were presented at the 2024 ASCO Annual Meeting, including promising outcomes in high-risk melanoma from the NADINA trial, as well as other new treatment options for patients with advanced cancers. TRANSCRIPT Dr. Diwakar Davar: Hello and welcome to the …
…
continue reading
1
Clinical Update on the Current Management of Advanced Urothelial Bladder Cancer
1:23:41
1:23:41
Play later
Play later
Lists
Like
Liked
1:23:41
Dr Petros Grivas from the Fred Hutchinson Cancer Center in Seattle, Washington, discusses the current management of advanced urothelial bladder cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.By Research To Practice
…
continue reading
1
Durvalumab's Benefit in SCLC "Beyond What We Might Have Expected"
10:29
10:29
Play later
Play later
Lists
Like
Liked
10:29
From ASCO 2024, Dr. Robert Figlin talks with Dr. Lauren Averett Byers from MD Anderson Cancer Center. Durvalumab's Benefit in SCLC "Beyond What We Might Have Expected"
…
continue reading
1
Doubts, Disbelief, and Delayed Diagnosis
1:04:54
1:04:54
Play later
Play later
Lists
Like
Liked
1:04:54
Multiple Myeloma ain't no joke, Black folks! A cancer of the bone marrow plasma cells, Myeloma is called “multiple” because there are frequently multiple patches or areas in bone marrow where it grows. In this episode, four men (three black and one white) come together to discuss the challenges they faced with delayed diagnosis of multiple myeloma …
…
continue reading
1
Adbry for Atopic Dermatitis, Augtyro for NTRK Tumors, Donanemab for Alzheimer's, Iqirvo for Primary Biliary Cholangitis, Retevmo in Thyroid Cancer, OTC Continuous Glucose Monitors
8:38
8:38
Play later
Play later
Lists
Like
Liked
8:38
Check out Nascentmc.com for medical writing assistance. visit learnAMAstyle.com for free downloads on medical writing and editing Adbry for Atopic Dermatitis The FDA has approved tralokinumab-ldrm (Adbry) as a 300 mg single-dose autoinjector for moderate-to-severe atopic dermatitis (AD) in adults, offering a more convenient delivery method. Adbry, …
…
continue reading
1
Revolutionizing Neuropsychiatry: Dr. Sam Clark Therapeutics and Innovation
32:10
32:10
Play later
Play later
Lists
Like
Liked
32:10
In this episode of Life Science Success, host Don interviews Dr. Sam Clark, founder and CEO of Terran Biosciences. They talk about Dr. Clark's innovative approach to creating new neuropsychiatric therapeutics and how his personal experiences with mental illness inspired him to enter the biotech industry. The episode also explores various breakthrou…
…
continue reading
1
Life Science Success with Vance Lyon: From Chemistry to Pharma Innovation
36:43
36:43
Play later
Play later
Lists
Like
Liked
36:43
In this episode of Life Science Success, host Don interviews Vance Lyon, an accomplished chemist with a four-decade career in the life sciences industry. Vance discusses his educational background, career journey, and key experiences. The conversation also delves into the vital role of Davos Pharma in providing comprehensive services for biotech co…
…
continue reading
1
S5 Ep10: Dhakal Reflects on the FDA Approval of Cilta-Cel for Earlier Lines of RRMM
20:11
20:11
Play later
Play later
Lists
Like
Liked
20:11
In this episode of Targeted Talks, Binod Dhakal, MD, MS, discusses the recent FDA approval of ciltacabtagene autoleucel for the treatment of relapsed/refractory multiple myeloma.By Targeted Talks
…
continue reading
1
A biomarker for disease severity in Wiskott-Aldrich Syndrome; loss of Dnmt3a confers resistance to IFNα; unrelated donor selection in HSCT with PTCy
19:16
19:16
Play later
Play later
Lists
Like
Liked
19:16
In this week's episode we'll discuss assessing risk profile in Wiskott-Aldrich Syndrome, or WAS. Then, we'll learn about how the loss of DNMT3A confers resistance to interferon-alpha in hematopoietic stem cells carrying the JAK2-V617F mutation. Finally, we'll explore unrelated donor selection for AML patients undergoing hematopoietic stem cell tran…
…
continue reading
1
New Standard of Care in Melanoma? Neoadjuvant Immunotherapy Offers "Fantastic" Potential, Expert Says
25:13
25:13
Play later
Play later
Lists
Like
Liked
25:13
From ASCO 2024 New Standard of Care in Melanoma? Neoadjuvant Immunotherapy Offers "Fantastic" Potential, Expert Says. Dr. Robert Figlin speaks with Dr. Christian Blank from Leiden University
…
continue reading
1
Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer
2:35:49
2:35:49
Play later
Play later
Lists
Like
Liked
2:35:49
Dr William J Gradishar from Northwestern Medicine Feinberg School of Medicine in Chicago, Illinois, Dr Virginia Kaklamani from UT Health San Antonio MD Anderson Cancer Center in Texas, Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Seth Wander from Massachusetts General Hospital in Boston, discuss key findings and…
…
continue reading
1
Dr. William Chou on Gene Therapy for Neurodegenerative Diseases
12:19
12:19
Play later
Play later
Lists
Like
Liked
12:19
In this episode of the Life Science Success Podcast, host Don Davis, PhD, MBA, interviews Dr. William Chou of Passage Bio. Dr. Chou discusses his transition from a practicing physician to a leader in biotechnology, reflects on the profound patient relationships he misses, and shares insights into Passage Bio's work on gene therapy for neurodegenera…
…
continue reading
1
Revolutionizing Gene Therapy with Igor Fisch CEO of NewBiologix
9:35
9:35
Play later
Play later
Lists
Like
Liked
9:35
In this episode of the Life Science Success Podcast, Don Davis PhD, MBA interviews Igor Fisch, founder of NewBiologix. Igor shares his journey from academia to entrepreneurship, highlighting his success with Selexis, a company he sold in 2017 that specialized in monoclonal antibodies. He discusses the challenges of gene therapy, specifically the hi…
…
continue reading
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer
1:00:48
1:00:48
Play later
Play later
Lists
Like
Liked
1:00:48
Dr Justin F Gainor from Massachusetts General Hospital in Boston and Dr Karen Reckamp from Cedars-Sinai Center in Los Angeles, California, summarize recently presented data on targeted therapy strategies for non-small cell lung cancer harboring actionable therapeutic targets, moderated by Dr Neil Love. Produced by Research To Practice. CME informat…
…
continue reading
1
Treating LR-MDS beyond ESA failure: currently approved agents, novel approaches & future outlooks
46:31
46:31
Play later
Play later
Lists
Like
Liked
46:31
While there have been advances in the treatment of lower-risk myelodysplastic syndromes (LR-MDS) in recent years, one major challenge that remains is the treatment of patients following the failure of erythropoiesis-stimulating agents (ESAs). In this podcast, experts Amer Zeidan, MBBS, Yale Cancer Center, New Haven, CT, Valeria Santini, MD, Univers…
…
continue reading
1
Should All Breast Cancer Patients Get T-DXd? "Results of DESTINY-Breast06 Do Suggest That"
10:46
10:46
Play later
Play later
Lists
Like
Liked
10:46
From ASCO 2024, Dr. Robert Figlin welcomes Dr. Aditya Bardia from UCLA Health Jonsson Comprehensive Cancer Center. Should All Breast Cancer Patients Get T-DXd? "Results of DESTINY-Breast06 Do Suggest That"
…
continue reading
1
Klisyri for Actinic Keratosis, MDMA for PTSD, Arexvy for RSV, Rytelo for MDS, Firdapse for LEMS
10:05
10:05
Play later
Play later
Lists
Like
Liked
10:05
Nascentmc.com for medical writing assistance for your company. Visit learnAMAstyle.com for free downloads on medical writing and editing Klisyri for Actinic Keratosis: The FDA has approved tirbanibulin (Klisyri) for treating actinic keratosis (AK) on larger areas of the face or scalp, up to 100 cm². Previously approved for areas up to 25 cm² in Dec…
…
continue reading
1
Exploring Neuroprotective Drugs with Dean Petkanas CEO of Kannalife Sciences
11:13
11:13
Play later
Play later
Lists
Like
Liked
11:13
In this episode of the Life Science Success Podcast, Dean Petkanas, co-founder of Kannalife Sciences, is interviewed at the Bio International Convention in San Diego. Dean shares his journey from investment banking in the 80s to founding Kannalife Sciences in 2009. He discusses the company's focus on developing cannabinoid-based drugs, specifically…
…
continue reading
1
Revolutionizing Lung Disease Treatment with Evoke Nano's CEO Sean Rothwell
19:00
19:00
Play later
Play later
Lists
Like
Liked
19:00
In this episode of the Life Science Success Podcast, host Don interviews Sean Rothwell, CEO of Evoke Nano, about the company's groundbreaking work in developing EBQ218, a revolutionary nanoparticle-based pulmonary therapeutic. They discuss the efficacy of EBQ218 in treating cystic fibrosis and its potential as a broad-spectrum antibiotic against dr…
…
continue reading
1
Virtual Human Twins: Revolutionizing Drug and Device Testing | Elem Biotech Pt2
20:07
20:07
Play later
Play later
Lists
Like
Liked
20:07
This is the second part of the interview where, with Maruiano, we will discuss more of the technology and development for Elem Biotech. In this episode of the Life Science Success Podcast, Don Davis discusses the BIO conference and the future of biomedical research with Mauriano Vázquez. They delve into the significance of networking events, the ev…
…
continue reading
1
Virtual Human Twins: Revolutionizing Drug and Device Testing | Elem Biotech Pt1
27:11
27:11
Play later
Play later
Lists
Like
Liked
27:11
There are two parts of this interview, in the first session, I dive into Elem and what the company is doing with Christopher Morton. In this exciting episode of Life Science Discussed Podcast, host Don Davis welcomes Christopher Morton, CEO of Elem Biotech, to talk about the groundbreaking work of virtual human twins in drug and medical device test…
…
continue reading
1
Breaking Barriers in Pain Management and ADHD Treatment with Tris Pharma James Hackworth
19:31
19:31
Play later
Play later
Lists
Like
Liked
19:31
In this episode of the Lifescience Success Podcast, host Don Davis interviews James Hackworth, who shares insights about his background in physics and his journey into the life science industry. James discusses his experiences from McKinsey up to his current role at Tris Pharma, focusing on their innovative drug development and formulation technolo…
…
continue reading
1
Innovating Biotech: Enzine's Continuous Manufacturing Platform with Himanshu Gadgil
6:18
6:18
Play later
Play later
Lists
Like
Liked
6:18
In this episode of the Life Science Success Podcast, Don interviews Himanshu Gadgil from Enzine during Bio International. Himanshu explains Enzine’s dual focus on developing biosimilars and their role as a CDMO with a game-changing platform, Enzine X. They discuss how Enzine's continuous manufacturing technology significantly cuts costs and speeds …
…
continue reading
1
Unifying Life Sciences: Unipr's Vision for Effortless Drug Development with AI
21:55
21:55
Play later
Play later
Lists
Like
Liked
21:55
Join us on the Life Science Success Podcast as we delve into the fascinating journey of Andy Mehrotra, a pharmacist turned entrepreneur, who pioneered Unipr, an AI and machine learning platform aimed at addressing inefficiencies in drug development. Learn about his transition from sales and marketing to leading an innovative company, the significan…
…
continue reading
1
Innovating Cancer Diagnostics: A Conversation with Jellox Biotech's Catherine Chung
15:52
15:52
Play later
Play later
Lists
Like
Liked
15:52
Welcome to the Life Science Success Podcast! In this episode, host Don interviews Catherine from Jellox Biotech at Bio Interntional June of 2024. Catherine shares insights into her journey from financial engineering to the life sciences field, her experience in investment banking, and her current role in business development at Jellox Biotech. She …
…
continue reading
1
Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer
1:02:31
1:02:31
Play later
Play later
Lists
Like
Liked
1:02:31
Dr Matthew Galsky from The Tisch Cancer Institute in New York and Dr Ashish Kamat from The University of Texas MD Anderson Cancer Center in Houston summarize recent clinical advances in the management of urothelial bladder cancer, including data from the 2024 AUA annual meeting, moderated by Dr Neil Love. Produced by Research To Practice. CME infor…
…
continue reading
1
Tisha Campbell - Overcoming Lung Disorder
49:37
49:37
Play later
Play later
Lists
Like
Liked
49:37
In this episode, Shanti Das discusses sarcoidosis and lung disease with dynamic guests in front of a live audience at the Johnson & Johnson headquarters in New Brunswick, NJ. Tisha Campbell has made her mark in the culture as an actress. Her well-known roles in Martin, My Wife and Kids, House Party, and Boomerang have made her an icon. Campbell ope…
…
continue reading
Dr. John Sweetenham shares highlights from Day 4 of the 2024 ASCO Annual Meeting, including exciting new data from the IMROZ trial in multiple myeloma, adjuvant therapy for triple-negative breast cancer in A-BRAVE, and the front-line treatment of advanced renal cell carcinoma in JAVELIN Renal-101. TRANSCRIPT Dr. John Sweetenham: I'm Dr. John Sweete…
…
continue reading
1
mRESVIA for Lower Respiratory Tract Disease, Breyanzi for R/R MCL, Sarclisa for ND MM, Onyda XR for ADHD, Bkemv for PNH and aHUS, Austedo in Huntington’s
9:29
9:29
Play later
Play later
Lists
Like
Liked
9:29
Go here for complete show notes. Visit learnAMAstyle.com for free downloads on medical writing and editing Nascentmc.com for medical writing assistance for your company. mRESVIA for Lower Respiratory Tract Disease The FDA approved mRNA-1345 (mRESVIA) for preventing RSV-caused lower respiratory tract disease in adults 60 and older, based on Phase 3 …
…
continue reading
1
BPDCN treatment and management: CD123-targeting agents, CNS involvement & approaching pediatric/AYA patients
34:39
34:39
Play later
Play later
Lists
Like
Liked
34:39
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive hematologic malignancy originating from plasmacytoid dendritic cells, characterized by skin lesions and frequent involvement of bone marrow and lymphoid tissues. Patients have a poor prognosis, making early diagnosis and advanced treatments, including targeted therapies, crucial …
…
continue reading
Dr. John Sweetenham shares highlights from Day 3 of the 2024 ASCO Annual Meeting, including selected studies on the treatment of cancer cachexia, surgical approaches in advanced ovarian cancer, and advanced colorectal cancer with liver metastases. TRANSCRIPT Dr. John Sweetenham: I'm Dr. John Sweetenham, the host of the ASCO Daily News Podcast, with…
…
continue reading
Dr. John Sweetenham shares highlights from Day 2 of the 2024 ASCO Annual Meeting, including potentially practice-changing results in advanced Hodgkin lymphoma, intriguing data on the effect of metformin on active surveillance for prostate cancer, and the potential of AI to improve patient outreach and adherence to medical appointments. TRANSCRIPT D…
…
continue reading
1
Breaking Barriers in Drug Development: Dr. David E. Martin CEO TrippBio
1:00:12
1:00:12
Play later
Play later
Lists
Like
Liked
1:00:12
In this episode of the Life Science Success podcast, we have Dr. David E. Martin, the President and CEO of TrippBio, Inc., a distinguished translational scientist with over 30 years of experience in drug development. Dr. Martin has led numerous groundbreaking projects and is here to share his insights on the future of therapeutic advancements. 🚀 Bo…
…
continue reading
In the first episode of a special daily series during the 2024 ASCO Annual Meeting, Dr. John Sweetenham shares highlights from Day 1, including exciting data on the CROWN trial in NSCLC, the ASC4First study in chronic myeloid leukemia, and the effects of high-deductible health plans on cancer survivorship. TRANSCRIPT Dr. John Sweetenham: I'm Dr. Jo…
…
continue reading
1
Hemophilia prophylaxis with fitusiran vs BPA/CFC; germline NBN variants in pediatric B-ALL; Histone demethylation and cell-intrinsic immune response in AML
18:59
18:59
Play later
Play later
Lists
Like
Liked
18:59
In this week's episode we'll learn about fitusiran prophylaxis in patients with hemophilia A or B, with or without inhibitors. Next we'll hear about new findings that heterozygous germline variants in the NBN gene that are linked to increased risk of B-cell acute lymphoblastic leukemia in children. Finally, we'll explore new insights on the histone…
…
continue reading
1
Oncology Today with Dr Neil Love: Key Presentations on Lymphoma from Recent Major Conferences
1:16:45
1:16:45
Play later
Play later
Lists
Like
Liked
1:16:45
Dr Andrew D Zelenetz from Memorial Sloan Kettering Cancer Center in New York City discusses recent updates on available and emerging treatment strategies for various lymphomas.By Neil Love, MD
…
continue reading
1
Episode 45. Updates in Primary Myelofibrosis with Dr. Ayalew Tefferi
1:00:53
1:00:53
Play later
Play later
Lists
Like
Liked
1:00:53
In this episode, we discuss updates in primary myelofibrosis with Dr. Ayalew Tefferi from the Mayo Clinic. The key studies and trials discussed are as follows: · GIPSS: Genetically inspired prognostic scoring system that is exclusively based on genetic markers. § https://www.nature.com/articles/s41375-018-0107-z · MIPSS70+ Version 2.0: Mutation and…
…
continue reading
1
Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
33:54
33:54
Play later
Play later
Lists
Like
Liked
33:54
Dr Elias Jabbour from the University of Texas MD Anderson Cancer Center in Houston discusses recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.By Neil Love, MD
…
continue reading